,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'enhertu']
updated: #asco22: enhertu blows chemotherapy out of the water, redefining breast cancer subgroups along the way endpoints news 
MS,MBA: Performance-driven professional, with a passion for Medicine, Biotechnology, Finance, Service Oriented Leadership and Entrepreneurship.